Concepedia

Publication | Open Access

Serum Interleukin 9 Levels Predict Disease Severity and the Clinical Efficacy of Infliximab in Patients with Crohnʼs Disease

DOIFull Paper Access

27

Citations

26

References

2017

Year

Ting Feng, Baili Chen, Li Li, Shanshan Huang, Shomron Ben‐Horin, Yun Qiu, Rui Feng, Manying Li, Ren Mao, Yao He,
Inflammatory Bowel Diseases

Abstract

Serum IL-9 levels correlate with disease severity and the clinical efficacy of IFX in patients with CD, and IL-9 may be a promising novel biomarker for CD monitoring.

References

YearCitations

Page 1